MiRKAT-S

A community-level test of association between the microbiota and survival times

Anna Plantinga, Xiang Zhan, Ni Zhao, Jun Chen, Robert R. Jenq, Michael C. Wu

Research output: Contribution to journalArticle

Abstract

Background: Community-level analysis of the human microbiota has culminated in the discovery of relationships between overall shifts in the microbiota and a wide range of diseases and conditions. However, existing work has primarily focused on analysis of relatively simple dichotomous or quantitative outcomes, for example, disease status or biomarker levels. Recently, there is also considerable interest in the relationship between the microbiota and censored survival outcomes, such as in clinical trials. How to conduct community-level analysis with censored survival outcomes is unclear, since standard dissimilarity-based tests cannot accommodate censored survival times and no alternative methods exist. Methods: We develop a new approach, MiRKAT-S, for community-level analysis of microbiome data with censored survival times. MiRKAT-S uses ecologically informative distance metrics, such as the UniFrac distances, to generate matrices of pairwise distances between individuals' taxonomic profiles. The distance matrices are transformed into kernel (similarity) matrices, which are used to compare similarity in the microbiota to similarity in survival times between individuals. Results: Simulation studies using synthetic microbial communities demonstrate correct control of type I error and adequate power. We also apply MiRKAT-S to examine the relationship between the gut microbiota and survival after allogeneic blood or bone marrow transplant. Conclusions: We present MiRKAT-S, a method that facilitates community-level analysis of the association between the microbiota and survival outcomes and therefore provides a new approach to analysis of microbiome data arising from clinical trials.

Original languageEnglish (US)
Article number17
JournalMicrobiome
Volume5
Issue number1
DOIs
StatePublished - 2017

Fingerprint

Microbiota
Survival
Clinical Trials
Biomarkers
Bone Marrow
Transplants

Keywords

  • Community-level analysis
  • Distance-based analysis
  • Kernel machine regression
  • Survival data

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

MiRKAT-S : A community-level test of association between the microbiota and survival times. / Plantinga, Anna; Zhan, Xiang; Zhao, Ni; Chen, Jun; Jenq, Robert R.; Wu, Michael C.

In: Microbiome, Vol. 5, No. 1, 17, 2017.

Research output: Contribution to journalArticle

Plantinga, Anna ; Zhan, Xiang ; Zhao, Ni ; Chen, Jun ; Jenq, Robert R. ; Wu, Michael C. / MiRKAT-S : A community-level test of association between the microbiota and survival times. In: Microbiome. 2017 ; Vol. 5, No. 1.
@article{884b1444e4164fbfb59a88a43ce704c4,
title = "MiRKAT-S: A community-level test of association between the microbiota and survival times",
abstract = "Background: Community-level analysis of the human microbiota has culminated in the discovery of relationships between overall shifts in the microbiota and a wide range of diseases and conditions. However, existing work has primarily focused on analysis of relatively simple dichotomous or quantitative outcomes, for example, disease status or biomarker levels. Recently, there is also considerable interest in the relationship between the microbiota and censored survival outcomes, such as in clinical trials. How to conduct community-level analysis with censored survival outcomes is unclear, since standard dissimilarity-based tests cannot accommodate censored survival times and no alternative methods exist. Methods: We develop a new approach, MiRKAT-S, for community-level analysis of microbiome data with censored survival times. MiRKAT-S uses ecologically informative distance metrics, such as the UniFrac distances, to generate matrices of pairwise distances between individuals' taxonomic profiles. The distance matrices are transformed into kernel (similarity) matrices, which are used to compare similarity in the microbiota to similarity in survival times between individuals. Results: Simulation studies using synthetic microbial communities demonstrate correct control of type I error and adequate power. We also apply MiRKAT-S to examine the relationship between the gut microbiota and survival after allogeneic blood or bone marrow transplant. Conclusions: We present MiRKAT-S, a method that facilitates community-level analysis of the association between the microbiota and survival outcomes and therefore provides a new approach to analysis of microbiome data arising from clinical trials.",
keywords = "Community-level analysis, Distance-based analysis, Kernel machine regression, Survival data",
author = "Anna Plantinga and Xiang Zhan and Ni Zhao and Jun Chen and Jenq, {Robert R.} and Wu, {Michael C.}",
year = "2017",
doi = "10.1186/s40168-017-0239-9",
language = "English (US)",
volume = "5",
journal = "Microbiome",
issn = "2049-2618",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - MiRKAT-S

T2 - A community-level test of association between the microbiota and survival times

AU - Plantinga, Anna

AU - Zhan, Xiang

AU - Zhao, Ni

AU - Chen, Jun

AU - Jenq, Robert R.

AU - Wu, Michael C.

PY - 2017

Y1 - 2017

N2 - Background: Community-level analysis of the human microbiota has culminated in the discovery of relationships between overall shifts in the microbiota and a wide range of diseases and conditions. However, existing work has primarily focused on analysis of relatively simple dichotomous or quantitative outcomes, for example, disease status or biomarker levels. Recently, there is also considerable interest in the relationship between the microbiota and censored survival outcomes, such as in clinical trials. How to conduct community-level analysis with censored survival outcomes is unclear, since standard dissimilarity-based tests cannot accommodate censored survival times and no alternative methods exist. Methods: We develop a new approach, MiRKAT-S, for community-level analysis of microbiome data with censored survival times. MiRKAT-S uses ecologically informative distance metrics, such as the UniFrac distances, to generate matrices of pairwise distances between individuals' taxonomic profiles. The distance matrices are transformed into kernel (similarity) matrices, which are used to compare similarity in the microbiota to similarity in survival times between individuals. Results: Simulation studies using synthetic microbial communities demonstrate correct control of type I error and adequate power. We also apply MiRKAT-S to examine the relationship between the gut microbiota and survival after allogeneic blood or bone marrow transplant. Conclusions: We present MiRKAT-S, a method that facilitates community-level analysis of the association between the microbiota and survival outcomes and therefore provides a new approach to analysis of microbiome data arising from clinical trials.

AB - Background: Community-level analysis of the human microbiota has culminated in the discovery of relationships between overall shifts in the microbiota and a wide range of diseases and conditions. However, existing work has primarily focused on analysis of relatively simple dichotomous or quantitative outcomes, for example, disease status or biomarker levels. Recently, there is also considerable interest in the relationship between the microbiota and censored survival outcomes, such as in clinical trials. How to conduct community-level analysis with censored survival outcomes is unclear, since standard dissimilarity-based tests cannot accommodate censored survival times and no alternative methods exist. Methods: We develop a new approach, MiRKAT-S, for community-level analysis of microbiome data with censored survival times. MiRKAT-S uses ecologically informative distance metrics, such as the UniFrac distances, to generate matrices of pairwise distances between individuals' taxonomic profiles. The distance matrices are transformed into kernel (similarity) matrices, which are used to compare similarity in the microbiota to similarity in survival times between individuals. Results: Simulation studies using synthetic microbial communities demonstrate correct control of type I error and adequate power. We also apply MiRKAT-S to examine the relationship between the gut microbiota and survival after allogeneic blood or bone marrow transplant. Conclusions: We present MiRKAT-S, a method that facilitates community-level analysis of the association between the microbiota and survival outcomes and therefore provides a new approach to analysis of microbiome data arising from clinical trials.

KW - Community-level analysis

KW - Distance-based analysis

KW - Kernel machine regression

KW - Survival data

UR - http://www.scopus.com/inward/record.url?scp=85015823653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015823653&partnerID=8YFLogxK

U2 - 10.1186/s40168-017-0239-9

DO - 10.1186/s40168-017-0239-9

M3 - Article

VL - 5

JO - Microbiome

JF - Microbiome

SN - 2049-2618

IS - 1

M1 - 17

ER -